ArticleScientific reports2026

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Yoshihiro Kitahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.